Reducing the impact of myocardial ischaemia/reperfusion injury

Cardiovascular Research

Volumn 94, Issue 2, 2012, Pages 165-167

  Piper, Hans Michael ^a   Garcia Dorado, David ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOPTOSIS INDUCING FACTOR; CALCIUM ANTAGONIST; CALCIUM ION; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; HEXOKINASE; HEXOKINASE 2; JUNCTIN; MALONYL COENZYME A DECARBOXYLASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NECROX 5; PYRUVATE DEHYDROGENASE; REGULATOR PROTEIN; SIRTUIN 3; STAT3 PROTEIN; TRIADIN; UNCLASSIFIED DRUG; ZAC1 PROTEIN;

APOPTOSIS; AUTOPHAGY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CYTOSOL; DIABETIC CARDIOMYOPATHY; DOWN REGULATION; ENZYME INHIBITION; GLUCOSE OXIDATION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; INDUCED HYPOTHERMIA; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; METABOLIC REGULATION; MITOCHONDRION; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

CALCIUM; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM;

EID: 84860155404     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs133     Document Type: Review

References (23)

1. Garcia-Dorado D, Ruiz-Meana M, Inserte J, Rodriguez-Sinovas A, Piper HM. Calciummediated cell death during myocardial reperfusion. Cardiovasc Res 2012;94:168-180.
2. Cai WF, Pritchard T, Florea S, Lam CK, Han P, Zhou X et al. Ablation of junctin or triadin is associated with increased cardiac injury following ischaemia/reperfusion. Cardiovasc Res 2012;94:333-341.
3. Miura T, Tanno M. The mPTP and its regulatory proteins: final common targets of signalling pathways for protection against necrosis. Cardiovasc Res 2012;94:181-189.
4. Ong SB, Gustafsson A° B. New roles for mitochondria in cell death in the reperfused myocardium. Cardiovasc Res 2012;94:190-196.
5. Thu VT, Kim HK, Long LT, Lee SR, Hanh TM, Ko TH et al. NecroX-5 prevents hypoxia/reoxygenation injury by inhibiting the mitochondrial calcium uniporter. Cardiovasc Res 2012;94:342-350.
6. Przyklenk K, Dong Y, Undyala VV, Whittaker P. Autophagy as a therapeutic target for ischaemia-reperfusion injury? Concepts, controversies, and challenges. Cardiovasc Res 2012;94:197-205.
7. Shi W, Vinten-Johansen J. Endogenous cardioprotection by ischaemic postconditioning and remote conditioning. Cardiovasc Res 2012;94:206-216.
8. Vincent A, Gahide G, Sportouch-Dukhan C, Covinhes A, Franck-Miclo A, Roubille F et al. Down-regulation of the transcription factor ZAC1 upon pre-and postconditioning protects against I/R injury in the mouse myocardium. Cardiovasc Res 2012;94: 351-358.
9. Ussher JR, Wang W, Gandhi M, Keung W, Samokhvalov V, Oka T et al. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovasc Res 2012;94:359-369.
10. Rui T, Zhang J, Xu X, Yao Y, Kao R, Martin CM. Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus. Cardiovasc Res 2012;94:370-378.
11. Tissier R, Ghaleh B, Cohen MV, Downey JM, Berdeaux A. Myocardial protection with mild hypothermia. Cardiovasc Res 2012;94:217-225.
12. Hinkel R, Boekstegers P, Kupatt C. Adjuvant early and late cardioprotective therapy: access to the heart. Cardiovasc Res 2012;94:226-236.
13. Heusch G, Kleinbongard P, Skyschally A, Levkau B, Schulz R, Erbel R. The coronary circulation in cardioprotection: more than just one confounder. Cardiovasc Res 2012;94:237-245.
14. Morel O, Perret T, Delarche N, Labèque JN, Jouve B, Elbaz M et al. Pharmacological approaches to reperfusion therapy. Cardiovasc Res 2012;94:246-252.
15. Hausenloy DJ, Boston-Griffiths E, Yellon DM. Cardioprotection during cardiac surgery. Cardiovasc Res 2012;94:253-265.
16. Bøtker HE, Kaltoft AK, Pedersen SF, Kim WY. Measuring myocardial salvage. Cardiovasc Res 2012;94:266-275.
17. Timmers L, Pasterkamp G, de Hoog VC, Arslan F, Appelman Y, de Kleijn DP. The innate immune response in reperfused myocardium. Cardiovasc Res 2012;94:276-283.
18. Zhu H, Fan GC. Role of microRNAs in the reperfused myocardium towards postinfarct remodelling. Cardiovasc Res 2012;94:284-292.
19. Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M et al. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res 2012;94:379-390.
20. Fraccarollo D, Galuppo P, Bauersachs J. Novel therapeutic approaches to postinfarction remodelling. Cardiovasc Res 2012;94:293-303.
21. Manoury B, Montiel V, Balligand JL. Nitric oxide synthase in post-ischaemic remodelling: new pathways and mechanisms. Cardiovasc Res 2012;94:304-315.
22. Ravassa S, Zudaire A, Díez J. GLP-1 and cardioprotection. From bench to bedside. Cardiovasc Res 2012;94:316-323.
23. Arenal Á, Hernández J, Perez-David E, Rubio-Guivernau JL, Ledesma-Carbayo MJ, Fernández-Avilés F. Do the spatial characteristics of myocardial scar tissue determine the risk of ventricular arrhythmias? Cardiovasc Res 2012;94:324-332.